ArticleJAMA network open2026
Extreme Risk Protection Order Policies and Suicide Risk Among Handgun Owners.
Article in JAMA network open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Importance: Extreme risk protection orders (ERPOs) are state laws intended to prevent gun violence by preemptively and temporarily removing firearms from gun owners judged to be at risk of self-harm or violence against others. Evidence of their population-level impact on suicide remains limited and mixed. Objective: To assess the association of California's ERPO law with suicide risk among lawful handgun owners. Design, Setting, and Participants: This cohort study used a difference-in-differences model, comparing suicide risk before (2012-2015) and after (2016-2021) implementation of California's ERPO law among handgun owners and nonowners, assuming parallel trends and that the law had no impact on suicide among nonowners. Data were from the Longitudinal Study of Handgun Ownership and Transfer (LongSHOT), which includes more than 38 million registered voters in California with firearm transaction and mortality records. Statistical analyses were conducted from March to June 2026. Exposure: Implementation of California's ERPO law on January 1, 2016. Main Outcomes and Measures: Death by all-cause suicide, firearm suicide, and nonfirearm suicide identified from mortality records using International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, codes. Risk differences were expressed as 1-year suicide deaths per 100 000 persons. Results: The analytic sample included approximately 172 million person-years (5 542 471 [nonunique] handgun owners and 166 624 345 [nonunique] nonowners aged 21 years or older). Handgun owners had a mean (SD) age of 44.4 (14.8) years in the prepolicy period and 47.2 (14.9) years in the postpolicy period. In both periods, most handgun owners were male (prepolicy period, 80.7%; and postpolicy period, 78.2%). Analyses showed a risk difference of -4.1 (95% CI, -9.5 to 1.3) suicide deaths per 100 000 persons in 1-year suicide risk among handgun owners following the implementation of the ERPO laws. Effect estimates were larger for firearm suicide (-3.0 [95% CI, -7.9 to 1.9]) compared with nonfirearm suicide (-1.1 [95% CI, -3.3 to 1.1]). Event study, subgroup, and negative control outcome analyses supported the main findings. Conclusions and Relevance: This cohort study of California's ERPO law and suicide risk among handgun owners estimated a modest population-level reduction in suicide risk, although a null effect cannot be ruled out, and such aggregate estimates do not necessarily imply ERPOs are ineffective among the individuals subjected to them. The findings reinforce the need for further research to understand the ways in which ERPOs can be used to reduce suicide.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.